NCT04076150View on ClinicalTrials.gov

Safety and Performance Study of the Optimum Transcatheter Aortic Valve

NARecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

December 18, 2022

Study Completion Date

May 18, 2027

Conditions
Severe Aortic Stenosis
Interventions
DEVICE

Transcatheter Aortic Valve (TAV) Implantation With The Optimum TAV System

Treating patients with severe symptomatic aortic stenosis via transcatheter aortic valve implantation by implanting the Optimum TAV inside the native diseased valve via a the Precision Catheter. The Optimum TAV and Precision Catheter together are the Optimum TAV System.

Trial Locations (1)

31-202

RECRUITING

John Paul II Hospital, Dept. of Interventional Cardiology, Krakow

Sponsors

Collaborators (1)

KCRI
All Listed Sponsors
collaborator

KCRI

OTHER

lead

Thubrikar Aortic Valve, Inc.

INDUSTRY